Plerixafor use for peripheral blood stem cell mobilization in Korea

참고문헌 (Reference)

1 Olivieri A, "Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo Italiano- Trapianto di Midollo Osseo" 47 : 342-351, 2012

2 Gordan LN, "Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation" 44 : 815-820, 2003

3 DiPersio JF, "Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma" 27 : 4767-4773, 2009

4 Basak GW, "Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization" 86 : 550-553, 2011

5 Weaver CH, "An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy" 86 : 3961-3969, 1995